Pharmaceutical

Biotheus and Hansoh Pharmaceutical expand ADC collaboration

Biotheus has announced an expansion of its strategic partnership with Hansoh Pharmaceutical Group for antibody-drug conjugates (ADCs).

Mar 16, 2024 - 00:00
Biotheus and Hansoh Pharmaceutical expand ADC collaboration
Biotheus has announced an expansion of its strategic partnership with Hansoh Pharmaceutical Group for antibody-drug conjugates (ADCs).
Read the original article

Tags:

Previous Article

FDA approves Madrigal’s Rezdiffra as the first NASH therapy

Next Article

Anocca signs licensing deal for EmendoBio’s gene-editing tech

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Advent receives US NIH grant for bronchopulmonary dysplasia therapy

Advent receives US NIH grant for bronchopulmonary dyspl...

Jul 19, 2023

ImPact enters partnership for pathologic myopia therapy development

ImPact enters partnership for pathologic myopia therapy...

Aug 14, 2023

STAT+: Massachusetts biotechs seek to piggyback on weight loss drug boom

STAT+: Massachusetts biotechs seek to piggyback on weig...

Oct 24, 2023